BWIN trades 2.0% below Wall Street's consensus target of $32.50.
Last 12 months price action with 12-month analyst target path
The base valuation assumes BWIN achieves its forward estimates and maintains a stable P/E multiple of 15.8x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of September 24, 2026, The Baldwin Insurance Group, Inc. (BWIN) has a Wall Street consensus price target of $32.50, based on estimates from 9 covering analysts. With the stock currently trading at $31.85, this represents a potential upside of +2.0%. The company has a market capitalization of $2.20B.
Analyst price targets range from a low of $28.00 to a high of $37.00, representing a 28% spread in expectations. The median target of $32.50 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 5 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, BWIN trades at a trailing P/E of -63.7x and forward P/E of 15.8x. Analysts expect EPS to grow +270.9% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $8.49, with bear and bull scenarios of $5.35 and $11.18 respectively. Model confidence stands at 62/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 RYANRyan Specialty Holdings, Inc. | $10.1B | $36.17 | $47.78 | +32.1% | Buy | 16.7x | 19 |
 AONAon plc | $59.7B | $281.60 | $387.30 | +37.5% | Hold | 15.0x | 38 |
 MMCMarsh & McLennan Companies, Inc. | $85.3B | $174.06 | $199.40 | +14.6% | Hold | 16.9x | 26 |
 WTWWillis Towers Watson Public Limited Company | $28.2B | $298.99 | $354.27 | +18.5% | Buy | 15.1x | 29 |
 BROBrown & Brown, Inc. | $20.6B | $61.70 | $72.50 | +17.5% | Hold | 13.7x | 31 |
 AJGArthur J. Gallagher & Co. | $59.0B | $229.64 | $285.00 | +24.1% | Buy | 17.3x | 29 |
 ERIEErie Indemnity Company | $10.4B | $225.77 | — | — | — | 17.8x | — |
 ACGLArch Capital Group Ltd. | $33.2B | $95.16 | $113.50 | +19.3% | Buy | 10.1x | 34 |
 HIGThe Hartford Insurance Group, Inc. | $34.7B | $126.59 | $151.33 | +19.5% | Buy | 9.9x | 42 |
 TRVThe Travelers Companies, Inc. | $75.2B | $360.39 | $351.11 | -2.6% | Hold | 10.6x | 44 |
Quick answers to the most common questions about buying BWIN stock.
The consensus price target for BWIN is $32.5, close to the current price of $31.85 (2.0% implied move). Based on 9 analyst estimates, the stock appears fairly valued near current levels.
BWIN has a consensus rating of "Buy" based on 9 Wall Street analysts. The rating breakdown is predominantly bullish, with 5 Buy/Strong Buy ratings. The consensus 12-month price target of $32.5 implies 2.0% upside from current levels.
With a forward P/E of 15.8418x, BWIN trades at a relatively low valuation. The consensus target of $32.5 implies 2.0% appreciation, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $37 for BWIN, while the most conservative target is $28. The consensus of $32.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $11 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
BWIN is moderately covered, with 9 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 4 have Buy ratings, 4 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month BWIN stock forecast based on 9 Wall Street analysts shows a consensus price target of $32.5, with estimates ranging from $28 (bear case) to $37 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $8, with bear/bull scenarios of $5/$11.
Our quantitative valuation model calculates BWIN's fair value at $8 (base case), with a bear case of $5 and bull case of $11. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 62/100.
BWIN trades at a forward P/E ratio of 15.8x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
BWIN appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $32.5 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
BWIN analyst price targets range from $28 to $37, a 28% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $32.5 consensus represents the middle ground. Our model's $5-$11 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.